Navigation Links
TargeGen Announces Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients
Date:1/31/2008

SAN DIEGO, Jan. 31 /PRNewswire/ -- TargeGen, Inc. today announced that the Company has started a multi-center Phase I/II clinical trial of TG101348, an oral, potent, and highly selective inhibitor of JAK2 in patients with myeloproliferative diseases.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030430/TARGEGENLOGO)

The V617F mutation of JAK2 is implicated in the pathogenesis of certain myeloproliferative diseases, including polycythemia vera (PV), essential thrombocytopenia (ET) and primary myelofibrosis (PMF). In preclinical models of myeloproliferative diseases, TG101348, administered orally, was shown to reduce V617F-expressing cell populations in a dose-dependant manner without adversely impacting normal hematopoeisis. The reduction of V617F-expressing cell populations correlated with improved survival and reduced morbidity. There are no currently approved specific therapies for PV, ET and PMF. These disorders are estimated to affect approximately 200,000 patients in the United States and more than twice that total worldwide.

The current clinical trial is being conducted at multiple centers in the USA. The trial is expected to enroll between 40-80 patients. Primary goals of this open label dose escalating protocol include identification of a maximum tolerated dose (MTD), accumulation of safety data, measurement of drug effect on surrogate markers, biomarkers, and presumptive clinical endpoints.

About TargeGen, Inc.

TargeGen, Inc. is a privately held vascular biology-focused biopharmaceutical company based in San Diego, CA. TargeGen primarily develops small molecule kinase inhibitors that target vascular leakage (edema), vascular proliferation (angiogenesis) and inflammation. Edema, angiogenesis and inflammation are involved in the pathology of many major human diseases.

TargeGen initiated operations in 2002 and has raised capital
'/>"/>

SOURCE TargeGen, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/15/2014)... , Sept. 15, 2014  Patients in today,s ... care more frequently in an outpatient setting versus a ... curve and to ensure that patients continue to receive ... the launch of its new internal medicine residency program. ... more often in office, clinic and even virtual settings. ...
(Date:9/15/2014)... /PRNewswire-iReach/ -- On September 8, 2014, Dr. ... a Citizen Petition to Dr. Margaret Hamburg ... another Black Box Warning to Levaquin, Cipro, and ... a Black Box Warning for the following psychiatric ... or acts, loss of consciousness, delirium, depressed level ...
(Date:9/15/2014)... , Sept. 15, 2014  Decision ... MedTech Physician™ 2014, finds that online information ... for brands to differentiate their offering and ... medical device purchasing decisions rely on websites, ... learning about devices—and these physicians are looking ...
Breaking Medicine Technology:Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 2Kaiser Permanente Hawaii Launches New Internal Medicine Residency Program 3Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 2Quinolone Vigilance Foundation Supports Citizen Petition Requesting Another Black Box Warning for Levaquin, Cipro, Avelox 3Physician device decision-makers show strong demand for device manufacturer digital content and support 2Physician device decision-makers show strong demand for device manufacturer digital content and support 3
(Date:9/16/2014)... September 16, 2014 Antioch University has ... Arts in Clinical Mental Health Counseling from Antioch ... list of programs offered through Antioch’s online campus. The ... January 2015. , "Antioch University New England’s MA in ... the field and a track record of preparing graduates ...
(Date:9/16/2014)... The rapidly increasing cost of compounded medications has ... PBMs as spending on these specialized drugs has catapulted ... concentrated, patient-specific practice, compounding has become commonplace in the ... Inc. (AIS), “Controlling the Cost of Compounded Medications: ... one leading health insurer and its internal PBM are ...
(Date:9/16/2014)... Madisonville, Louisiana (PRWEB) September 16, 2014 ... packaging for one of its most popular products - ... been designed to educate the general public about the ... weight management and building lean muscle mass. As well ... now detail product benefits, supplement facts, and nutritional information ...
(Date:9/16/2014)... 16, 2014 The Living Ethics lecture ... fall. Reflecting on what it means to live in ... investigates unique and thought-provoking topics. , “The Museum’s job ... to look at their world differently. The Living ... stage for truly enlightening dialogue,” says Richard Conti, Chief ...
(Date:9/16/2014)... September 16, 2014 DiaperBuys, a national ... ‘Healthy Aging’ Month this September. Healthy Aging Month was ... across the nation on the positive aspects of growing ... with conditions or side effects from medications that cause ... Outreach Manager for DiaperBuys.com. “This can seem daunting to ...
Breaking Medicine News(10 mins):Health News:Antioch University Launches Online Master’s Degree Program in Clinical Mental Health Counseling 2Health News:Sept. 25 Webinar to Offer Health Plan, Employer Strategies to Control Compounded Medication Costs 2Health News:BQuick Nutrition Announces Newly Branded BURN Clarinol CLA Powder 2Health News:BQuick Nutrition Announces Newly Branded BURN Clarinol CLA Powder 3Health News:Expanding Community Vision at the Science Museum of Virginia 2Health News:DiaperBuys Honors ‘Healthy Aging’ Month throughout September 2Health News:DiaperBuys Honors ‘Healthy Aging’ Month throughout September 3
... Md., Dec. 4 Nabi,Biopharmaceuticals (Nasdaq: ... completed the,sale of assets constituting its Biologics ... a wholly-owned subsidiary of Biotest,AG, for $185 ... arrangements described,below, Biotest has acquired or will ...
... 4 ConsumerLab.com, LLC claims to,be a leading provider ... and healthcare professionals evaluate health, wellness, and,nutrition products. ... of,Revatrol, a red-wine 100MG resveratrol supplement -- is ... by ConsumerLab.com on red wine,supplements analyzed a formulation ...
... more than one in ten infants in the U.S. is ... problems associated with premature births is brittle bones, or osteopenia ... in the infant, and osteoporosis later in life. , ... that aims to make preemies bones stronger. Dr. Dan Nemet ...
... Florida State University professor will share a $3.3 million ... Vermont to develop an innovative method that will help ... psychology Professor Brad Schmidt and UVM psychology Professor Michael ... each campus -- to participate in the study over ...
... In response to the growing body of research ... for Cancer Research (AACR) announces the launch of a ... submissions of papers. This important new journal is the ... from preclinical research to clinical trials. , In the ...
... that only vertebrates have sophisticated adaptive immune systems that ... being infected by them just once has been revised ... also have a form of immune memory that protects ... encountered. This was just one of the striking discoveries ...
Cached Medicine News:Health News:Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG 2Health News:Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG 3Health News:Renaissance Health Publishing, LLC Asks Key Credibility Questions of ConsumerLab.com 2Health News:Tel Aviv University gives preemies a fighting chance 2Health News:FSU researcher lands $3.3 million grant to help smokers kick habit 2Health News:AACR introduces Cancer Prevention Research 2Health News:AACR introduces Cancer Prevention Research 3Health News:Violent sex acts boost insect's immunity system 2Health News:Violent sex acts boost insect's immunity system 3
The original battery-operated suction and irrigation system features a new ergonomic hand piece and superior performance characteristics that have increased the overall flow rate....
... Bringing together the best of both ... intraocular instrument is the latest addition ... lightweight Eraser bipolar cautery instruments for ... hemostasis with extrusion aspiration and backflush ...
...
...
Medicine Products: